<html>
<head>
<title>Utah Legislature HB0130</title>
</head>
<body>
<div id="content">
<font face="Arial">
</font><font face="Arial" size="3">1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center><b>CANNABINOID MEDICINE RESEARCH</b></font><font face="Arial" size="2"></center><br/>2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>2017 GENERAL SESSION</center><br/>3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>STATE OF UTAH</center><br/>4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3"><b>Chief Sponsor:  Brad M. Daw</b></font><font face="Arial" size="2"></center><br/>5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3">Senate Sponsor: </font><font face="Arial" size="2"></font><font face="Arial" size="3">  Evan J. Vickers</font><font face="Arial" size="2"></center><br/>6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/>7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>LONG TITLE</b><br/>8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>General Description:</b><br/>9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill enacts provisions related to research of cannabis and cannabinoid medicine.<br/>10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Highlighted Provisions:</b><br/>11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill:<br/>12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;allows a person to possess cannabis, cannabinoid medicine, and expanded<br/>13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;cannabinoid medicine and to distribute the cannabis, cannabinoid medicine, or<br/>14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;expanded cannabinoid medicine to a patient pursuant to an institutional review<br/>15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;board-approved study; and<br/>16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;allows a person conducting an institutional review board-approved study to import<br/>17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and distribute cannabis, cannabinoid medicine, and expanded cannabinoid medicine<br/>18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;under certain circumstances.<br/>19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Money Appropriated in this Bill:</b><br/>20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None<br/>21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Other Special Clauses:</b><br/>22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill provides a special effective date.<br/>23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Utah Code Sections Affected:</b><br/>24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ENACTS:<br/>25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#26-59-101">26-59-101</a></b>, Utah Code Annotated 1953<br/>26&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#26-59-102">26-59-102</a></b>, Utah Code Annotated 1953<br/>27&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#26-59-103">26-59-103</a></b>, Utah Code Annotated 1953<br/><hr>28&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-37-3.6">58-37-3.6</a></b>, Utah Code Annotated 1953<br/>29&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/>30&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Be it enacted by the Legislature of the state of Utah:</i><br/>31&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 1.  Section <b>26-59-101</b><a name="26-59-101"></a> is enacted to read:<br/>32&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center><b>CHAPTER 59. CANNABINOID MEDICINE RESEARCH ACT</b></center><br/>33&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26-59-101.</u></b>  <b>Title.</b><br/>34&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>This chapter is known as "Cannabinoid Medicine Research Act."</u><br/>35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 2.  Section <b>26-59-102</b><a name="26-59-102"></a> is enacted to read:<br/>36&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26-59-102.</u></b>  <b>Definitions.</b><br/>37&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>As used in this chapter:</u><br/>38&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  "Approved study" means a medical research study:</u><br/>39&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  the purpose of which is to investigate the medical benefits of cannabinoid medicine;</u><br/>40&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>and</u><br/>41&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  that is approved by an IRB.</u><br/>42&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2)  "Cannabinoid medicine" means the same as that term is defined in Section</u><br/>43&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u><a href="#58-37-3.6">58-37-3.6</a>.</u><br/>44&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(3)  "Cannabis" means the same as that term is defined in Section <a href="#58-37-3.6">58-37-3.6</a>.</u><br/>45&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(4)  "Institutional review board" or "IRB" means an institutional review board that is</u><br/>46&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>registered for human subject research by the United States Department of Health and Human</u><br/>47&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Services.</u><br/>48&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 3.  Section <b>26-59-103</b><a name="26-59-103"></a> is enacted to read:<br/>49&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26-59-103.</u></b>  <b>Institutional review board -- Approved study, cannabis, cannabinoid</b><br/>50&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>medicine, or expanded cannabinoid medicine.</b><br/>51&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  A person conducting an approved study may, for the purposes of the study:</u><br/>52&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  process cannabinoid medicine or expanded cannabinoid medicine;</u><br/>53&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  possess cannabinoid medicine or expanded cannabinoid medicine; and</u><br/>54&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  administer a product containing cannabis, cannabinoid medicine, or expanded</u><br/>55&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>cannabinoid medicine to an individual in accordance with the approved study.</u><br/>56&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2)  A person conducting an approved study may:</u><br/>57&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  import cannabis, cannabinoid medicine, or expanded cannabinoid medicine from</u><br/>58&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>another state if:</u><br/><hr>59&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  the importation complies with federal law; and</u><br/>60&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  the person uses the cannabis, cannabinoid medicine, or expanded cannabinoid</u><br/>61&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>medicine in accordance with the approved study; or</u><br/>62&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  obtain cannabis, cannabinoid medicine, or expanded cannabinoid medicine from</u><br/>63&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>the National Institute on Drug Abuse.</u><br/>64&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(3)  A person conducting an approved study may distribute, outside the state, cannabis,</u><br/>65&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>cannabinoid medicine, or expanded cannabinoid medicine if:</u><br/>66&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  the distribution complies with federal law; and</u><br/>67&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  the distribution is for the purposes of, and in accordance with, the approved study.</u><br/>68&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 4.  Section <b>58-37-3.6</b><a name="58-37-3.6"></a> is enacted to read:<br/>69&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;58-37-3.6.</u></b>  <b>Exemption for possession or distribution of cannabinoid medicine</b><br/>70&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>pursuant to an approved study.</b><br/>71&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  As used in this section:</u><br/>72&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  "Cannabinoid medicine" means a product intended for human ingestion that:</u><br/>73&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  contains an extract or concentrate that is obtained from cannabis;</u><br/>74&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  is prepared in a medicinal dosage form; and</u><br/>75&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iii)  contains at least 10 units of cannabidiol for every one unit of tetrahydrocannabinol.</u><br/>76&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  "Cannabis" means any part of the plant cannabis sativa, whether growing or not.</u><br/>77&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  "Drug paraphernalia" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-37a-3&session=2017GS">58-37a-3</a>.</u><br/>78&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(d)  "Expanded cannabinoid medicine" means a product intended for human ingestion</u><br/>79&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>that:</u><br/>80&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  contains an extract or concentrate that is obtained from cannabis;</u><br/>81&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  is prepared in a medicinal dosage form; and</u><br/>82&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iii)  contains less than 10 units of cannabidiol for every one unit of</u><br/>83&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>tetrahydrocannabinol.</u><br/>84&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(e)  "Medicinal dosage form" means:</u><br/>85&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  a tablet;</u><br/>86&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  a capsule;</u><br/>87&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iii)  a concentrated oil;</u><br/>88&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iv)  a liquid suspension;</u><br/>89&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(v)  a transdermal preparation; or</u><br/><hr>90&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(vi)  a sublingual preparation.</u><br/>91&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(f)  "Tetrahydrocannabinol" means a substance derived from cannabis that meets the</u><br/>92&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>description in Subsection <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-37-4&session=2017GS">58-37-4</a>(2)(a)(iii)(AA).</u><br/>93&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2)  Notwithstanding any other provision of this chapter, an individual who possesses or</u><br/>94&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>distributes cannabinoid medicine or expanded cannabinoid medicine is not subject to the</u><br/>95&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>penalties described in this title for the possession or distribution of marijuana or</u><br/>96&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>tetrahydrocannabinol to the extent that the individual's possession or distribution of</u><br/>97&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>cannabinoid medicine or expanded cannabinoid medicine complies with Title 26, Chapter 59,</u><br/>98&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Cannabinoid Medicine Research Act.</u><br/>99&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 5.  <b>Effective date.</b><br/>100&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>If approved by two-thirds of all the members elected to each house, this bill takes effect</u><br/>101&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>upon approval by the governor, or the day following the constitutional time limit of Utah</u><br/>102&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Constitution, Article VII, Section 8, without the governor's signature, or in the case of a veto,</u><br/>103&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>the date of veto override.</u><br/><br/><hr style="width:90%; color: #333; text-align: right" /><br/><hr style="width:90%; color: #333; text-align: right" /><br/><br/><b>Legislative Review Note<br/>Office of Legislative Research and General Counsel</b>
</font>
</div>
</body>
</html>
